JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Expressive Writing for COVID-19 Resilience

Not Applicable

Completed

Conditions: Distress Due to COVID-19

Interventions: Behavioral: Expressive writing

First Posted Date: 2020-10-19

Last Posted Date: 2020-10-19

Lead Sponsor: Duke University

Target Recruit Count: 63

Registration Number: NCT04589104

Locations: 🇺🇸
Duke Integrative Medicine, Durham, North Carolina, United States

Coping Together: Couple-based Interventions for Cancer

Not Applicable

Recruiting

Conditions: Advanced Cancer

Interventions: Behavioral: Couple Communication Skills Training
Behavioral: Healthy Lifestyle Information

First Posted Date: 2020-10-19

Last Posted Date: 2024-04-17

Lead Sponsor: Duke University

Target Recruit Count: 460

Registration Number: NCT04590885

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Expressive Writing for COVID-19 Resilience for Parents

Not Applicable

Completed

Conditions: Parents During COVID-19

Interventions: Behavioral: Expressive writing

First Posted Date: 2020-10-19

Last Posted Date: 2021-11-24

Lead Sponsor: Duke University

Target Recruit Count: 11

Registration Number: NCT04589117

Locations: 🇺🇸
Duke Integrative Medicine, Durham, North Carolina, United States

Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis

Phase 1

Not yet recruiting

Conditions: Juvenile Idiopathic Arthritis
Obesity
Rheumatoid Arthritis

Interventions: Drug: Etanercept Optimal dosing

First Posted Date: 2020-10-14

Last Posted Date: 2024-07-18

Lead Sponsor: Duke University

Target Recruit Count: 30

Registration Number: NCT04585711

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

Not Applicable

Completed

Conditions: Sickle Cell Disease
Hematologic Diseases
Anemia, Sickle Cell
Genetic Disease

Interventions: Other: Electronic Health Record (EHR) Embedded Individualized Pain Plan (IPP)

First Posted Date: 2020-10-14

Last Posted Date: 2022-10-28

Lead Sponsor: Duke University

Target Recruit Count: 279

Registration Number: NCT04584528

Locations: 🇺🇸
University of Illinois, Chicago, Illinois, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
St. Jude's, Memphis, Tennessee, United States

and more 5 locations

Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families

Not Applicable

Completed

Conditions: Family Members
Patients
Brain Injuries, Traumatic
Transitional Care

Interventions: Behavioral: BETTER Transitional Care Intervention

First Posted Date: 2020-10-14

Last Posted Date: 2024-11-15

Lead Sponsor: Duke University

Target Recruit Count: 31

Registration Number: NCT04584554

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Lift Mobile Mindfulness for COVID-19 Distress Symptoms

Not Applicable

Completed

Conditions: COVID-19
Cardiorespiratory Failure

Interventions: Behavioral: Lift

First Posted Date: 2020-10-09

Last Posted Date: 2023-11-07

Lead Sponsor: Duke University

Target Recruit Count: 56

Registration Number: NCT04581200

Locations: 🇺🇸
University of Colorado - Denver, Aurora, Colorado, United States
🇺🇸
Oregon Health & Sciences University, Portland, Oregon, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

and more 1 locations

Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)

Phase 2

Completed

Conditions: Chronic Heart Failure

Interventions: Drug: Splanchnic nerve block

First Posted Date: 2020-10-05

Last Posted Date: 2023-06-27

Lead Sponsor: Duke University

Target Recruit Count: 5

Registration Number: NCT04575428

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Completed

Conditions: E Coli Infection

Interventions: Other: no Intervention

First Posted Date: 2020-10-05

Last Posted Date: 2021-07-27

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT04574596

Locations: 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

and more 10 locations

Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

Not Applicable

Completed

Conditions: Lymphedema of Upper Arm
Breast Cancer
Melanoma
Thoracic Cancer

Interventions: Other: Ipsilateral peripheral IV insertion

First Posted Date: 2020-09-30

Last Posted Date: 2023-04-25

Lead Sponsor: Duke University

Target Recruit Count: 3

Registration Number: NCT04570722

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy